ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 372 filers reported holding ASTRAZENECA PLC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,399,140 | -11.7% | 64,961 | -6.6% | 0.04% | -9.3% |
| Q2 2023 | $4,982,179 | -0.1% | 69,523 | -3.3% | 0.04% | -10.4% |
| Q1 2023 | $4,987,896 | +45.6% | 71,862 | +2.4% | 0.05% | -72.1% |
| Q4 2022 | $3,424,931 | -9.0% | 70,202 | +2.3% | 0.17% | +300.0% |
| Q3 2022 | $3,764,000 | -44.1% | 68,645 | -32.7% | 0.04% | -28.3% |
| Q2 2022 | $6,737,000 | +2.3% | 101,974 | +2.8% | 0.06% | +20.0% |
| Q1 2022 | $6,583,000 | +17.0% | 99,223 | +2.7% | 0.05% | +19.0% |
| Q4 2021 | $5,626,000 | -45.0% | 96,581 | -43.3% | 0.04% | -35.4% |
| Q3 2021 | $10,225,000 | +106.1% | 170,251 | +105.5% | 0.06% | +51.2% |
| Q2 2021 | $4,962,000 | +20.6% | 82,833 | +0.1% | 0.04% | +10.3% |
| Q1 2021 | $4,114,000 | +104.1% | 82,749 | +105.3% | 0.04% | +85.7% |
| Q4 2020 | $2,016,000 | +17.4% | 40,314 | +26.6% | 0.02% | -4.5% |
| Q3 2020 | $1,717,000 | +12.6% | 31,847 | +10.4% | 0.02% | +4.8% |
| Q2 2020 | $1,525,000 | +26.1% | 28,837 | +6.5% | 0.02% | -4.5% |
| Q1 2020 | $1,209,000 | -4.4% | 27,081 | +6.7% | 0.02% | +10.0% |
| Q4 2019 | $1,265,000 | -43.1% | 25,388 | -46.9% | 0.02% | -42.9% |
| Q3 2019 | $2,225,000 | +27.7% | 47,773 | +10.5% | 0.04% | +12.9% |
| Q2 2019 | $1,742,000 | +58.2% | 43,251 | +58.7% | 0.03% | +40.9% |
| Q1 2019 | $1,101,000 | +38.5% | 27,247 | +30.2% | 0.02% | +15.8% |
| Q4 2018 | $795,000 | -39.2% | 20,926 | -36.7% | 0.02% | -29.6% |
| Q3 2018 | $1,308,000 | -42.1% | 33,057 | -48.7% | 0.03% | -27.0% |
| Q2 2018 | $2,258,000 | +258.4% | 64,479 | +257.9% | 0.04% | +48.0% |
| Q1 2018 | $630,000 | -65.7% | 18,015 | -65.4% | 0.02% | -67.9% |
| Q4 2017 | $1,835,000 | +35.6% | 52,071 | +32.5% | 0.08% | +136.4% |
| Q3 2017 | $1,353,000 | +24.0% | 39,294 | +21.2% | 0.03% | +10.0% |
| Q2 2017 | $1,091,000 | -34.4% | 32,426 | -47.0% | 0.03% | -36.2% |
| Q1 2017 | $1,663,000 | +146.7% | 61,228 | +155.4% | 0.05% | +113.6% |
| Q4 2016 | $674,000 | +19.3% | 23,977 | +38.5% | 0.02% | -4.3% |
| Q3 2016 | $565,000 | +0.2% | 17,308 | -7.7% | 0.02% | 0.0% |
| Q2 2016 | $564,000 | +24.8% | 18,743 | +16.7% | 0.02% | +4.5% |
| Q1 2016 | $452,000 | -25.2% | 16,056 | -9.8% | 0.02% | -24.1% |
| Q4 2015 | $604,000 | +20.8% | 17,800 | +13.3% | 0.03% | +7.4% |
| Q3 2015 | $500,000 | +1.2% | 15,710 | +102.6% | 0.03% | +17.4% |
| Q2 2015 | $494,000 | -4.8% | 7,753 | +2.2% | 0.02% | -23.3% |
| Q1 2015 | $519,000 | -6.5% | 7,587 | -3.8% | 0.03% | -16.7% |
| Q4 2014 | $555,000 | -35.7% | 7,883 | -34.7% | 0.04% | -40.0% |
| Q3 2014 | $863,000 | -3.8% | 12,077 | +0.1% | 0.06% | -22.1% |
| Q2 2014 | $897,000 | +9.4% | 12,067 | -4.6% | 0.08% | -10.5% |
| Q1 2014 | $820,000 | +5.5% | 12,645 | -3.4% | 0.09% | -1.1% |
| Q4 2013 | $777,000 | – | 13,090 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |